ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 670785 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 670785; 2) Community: the network communities that were significantly associated with the response to NSC 670785; 3) Molecule: the relationships between components within communities and NSC 670785; 4) MDR: the compounds that were significantly associated with the NSC 670785.

NSC Compound Enrichment Correlation
NSC 676532 Ether-20 0.0217366743178497 0.18842888
NSC 681972 Null 0.0217366743178497 -0.043940148
NSC 686551 Null 0.0217366743178497 0.15035938
NSC 693248 Null 0.0217366743178497 0.6200909
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.0217366743178497 0.12773849
NSC 709974 Null 0.0217366743178497 0.45839538
NSC 718564 Null 0.0217366743178497 0.26346291
NSC 718781 Erlotinib hydrochloride 0.0217366743178497 0.046063331
NSC 726217 Combretastatin A4-analogue 0.0217366743178497 0.19104732
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0217366743178497 0.41675875
Total:122  Current:61    [First] [Prev] [Next] [Last]